Steven Cohen Merus N.V. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Merus N.V. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 11,008 shares of MRUS stock, worth $613,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,008Holding current value
$613,035% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding MRUS
# of Institutions
165Shares Held
47.9MCall Options Held
123KPut Options Held
293K-
Commodore Capital LP New York, NY4.36MShares$243 Million16.96% of portfolio
-
Rtw Investments, LP New York, NY4.11MShares$229 Million2.97% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.65MShares$148 Million2.46% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.25MShares$125 Million0.24% of portfolio
-
Samlyn Capital, LLC New York, NY2.08MShares$116 Million1.66% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.55B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...